Celcuity (CELC) Gains 6.51% on Investor Interest in Solid‑Tumor Biotech Pipeline
Celcuity (CELC) jumps 6.5% on investor excitement over its precision oncology pipeline—discover what’s fueling the surge and future upside potential.
3 minutes to read
CELCUITY INC